Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Search help

14 results

  1. Non-pharmacological interventions for people living with dementia - Dementia - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK536485
    ... souvenaid versus placebo. 13.2.4.9.4. Huperzine A Very low- to low-quality evidence from ... with mild to moderate Alzheimer’s disease offered Huperzine A versus placebo or no intervention. Moderate-quality ...
  2. Meta-analysis & network meta-analysis results - Dementia - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK536506
    ... Souvenaid Cognition (post-intervention) ADCS-ADL (post-intervention) Huperzine A MMSE (post-intervention) ADL (post-intervention) BPSD ( ...
  3. References - Dementia - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK536508
    ... JD, Sou ML. Double-blind controlled treatment of huperzine-A and placebo in 28 patients with Alzheimer ... Disease Cooperative Study. A phase II trial of huperzine A in mild to moderate Alzheimer disease. Neurology. ...
  4. Excluded References - Diagnosis and Treatment of Clinical Alzheimer’s-Type Dementia: A Systematic Review - NCBI ... 
    https://www.ncbi.nlm.nih.gov/books/NBK556577
    ... Ding JM, Zhong P, et al. Impacts of huperzine A on the level of Fas, Apo2.7 ... al. Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer’s disease: ...
  5. Excluded studies - Dementia - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK536486
    ... Li WN, Yu HY (2011) The efficacy of Huperzine A in treating mild to moderate Data not ... Shi W, Chen XH (2013) Clinical study of huperzine A on patients with mild and moderate Alzheimer ...
  6. Key Question 4: Supplements Versus Placebo for Cognition, Function, and Quality of Life - Diagnosis and Treatment of ... 
    https://www.ncbi.nlm.nih.gov/books/NBK556562
    ... efficacy or harms of Prevagen (apoaequorin), phosphotidylserine or Huperzine. Baseline Study Characteristics Eight publications reporting eight trials ...
  7. Discussion - Diagnosis and Treatment of Clinical Alzheimer’s-Type Dementia: A Systematic Review - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK556543
    ... We found no eligible studies for Prevagen (apoaequorin), huperzine or phosphatidylserine. Our findings are mostly consistent with ...
  8. Introduction - Diagnosis and Treatment of Clinical Alzheimer’s-Type Dementia: A Systematic Review - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK556567
    ... interest (e.g., cannabinoids, ginseng, omega 3, gingko, huperzine A), a new comprehensive systematic review examining the ...
  9. Excluded References - Interventions to Prevent Age-Related Cognitive Decline, Mild Cognitive Impairment, and Clinical ... 
    https://www.ncbi.nlm.nih.gov/books/NBK442416
    ... Liang XM, Juan W, et al. Treatment with Huperzine A improves cognition in vascular dementia patients. Cell ...